Language selection

Government of Canada / Gouvernement du Canada

Search

HEK293 expression platform (L-10894/11266/11565) .: NR16-179/2017E-PDF

“There is an increasing demand for biopharmaceuticals such as vaccines, humanized monoclonal antibodies, and gene therapy products produced from animal cell culture processes. The NRC’s HEK293 expression system enables the high yield production of viral vector and post-translationally modified recombinant proteins through suspension-growing, serum-free adapted cell lines. It provides an optimized, chemically defined formulation for serum-free suspension culture of this cell line. The cell line can be used in combination with the cumate and coumermycin switches, which enable producers to turn on the expression of a given protein only when needed”--Highlights.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847672&sl=0

Publication information
Department/Agency
  • National Research Council Canada.
TitleHEK293 expression platform (L-10894/11266/11565) .
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Plateforme d’expression HEK293 (L-10894/11266/11565).
  • Caption title.
  • "December 2017."
  • Issued also in print format.
Publishing information
  • [Ottawa] : National Research Council Canada, [2018]
Description[1] p.
ISBN9780660239897
Catalogue number
  • NR16-179/2017E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: